Lee Tien-Li 4
4 · Aardvark Therapeutics, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock option (right to buy)
2025-06-11+549,534→ 549,534 totalExercise: $11.29Exp: 2035-06-11→ Common Stock (549,534 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on June 11, 2026, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.